# Persephone Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/persephone-biosciences

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.persephonebiosciences.com
- Total disclosed funding: $15M
- Latest round: Seed (Jul 13, 2022)
- Investors on record: 8

## About

Based in California, US, and founded in 2017 by CEO Stephanie Culler, and CTO Steve Van Dien, Persephone Biosciences, Inc., a.k.a. Persephone operates as a developer of microbiome-based medicines for immuno-oncology applications. In July 2022, Persephone Biosciences, Inc. raised USD 15 million in seed funding co-led by First Bight Ventures, and Propel Bio Partners, with participation from BrightEdge Ventures, Fifty Years, ZhenFund, Pioneer Fund, Susa Ventures, and Y Combinator.

The company is developing a platform to industrialize the development of engineered cells that restore health to damaged human ecosystems. Persephone uses synthetic biology for the development of microbial products, impacting patient and infant health. In addition, the firm has conducted multiple clinical research programs, including My Baby Biome, ARGONAUT, and Poop for the Cure.

The company plans to use its proceeds from July 2022 funding to expand its research and clinical programs as well as pursue new collaborations.

## Funding rounds

- Seed, Jul 13, 2022, $15M — Y Combinator, ZhenFund, Susa Ventures, Pioneer Fund, Fifty Years, BrightEdge Ventures, First Bight Ventures, Propel Bio Partners

## Investors

- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Seed
- ZhenFund (https://capitalatlas.ai/funds/zhenfund) — Seed
- Susa Ventures (https://capitalatlas.ai/funds/susa-ventures) — Seed
- Pioneer Fund (https://capitalatlas.ai/funds/pioneer-fund) — Seed
- Fifty Years (https://capitalatlas.ai/funds/fifty-years) — Seed
- BrightEdge Ventures (https://capitalatlas.ai/funds/brightedge-ventures) — Seed
- First Bight Ventures (https://capitalatlas.ai/funds/first-bight-ventures) — Seed
- Propel Bio Partners (https://capitalatlas.ai/funds/propel-bio-partners) — Seed
